FilingReader Intelligence
Hatay Pharmaceutical profit falls 32% on higher costs
July 28, 2025 at 06:04 PM UTC•By FilingReader AI
Hatay Pharmaceutical reported a 32.16% decrease in profit after tax for Q2 2025, falling to VND 11.8 billion from VND 17.5 billion in Q2 2024.
The decline was driven by a 15.25% increase in selling and administrative expenses to VND 26.8 billion. Financial expenses also rose 36.59% to VND 9.4 billion due to foreign exchange rate fluctuations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HNX:DHT•Hanoi Stock Exchange
News Alerts
Get instant email alerts when HaTay Pharmaceutical JSC publishes news
Free account required • Unsubscribe anytime